2-propylquinoline-4-carboxylic acid, 5g

Acetoacetic acid ethyl ester, min. 98%, 500 ml, glass packaging

3,5-Dimethyl-1-hexyn-3-ol>98.0%(GC)25mL

Ethyl 1-(5-fluoropyridin-2-yl)piperidine-4-carboxylate, 95%, 1g

2,4-Dichloro-5-(chloromethyl)pyridine, 95.0%, 1g

(3-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid, 97%, 250mg

6-IODO-3,4-DIHYDRO-1H-QUINOLIN-2-ONE, 97.0%, 5g

2,5-Dimethylphenylmethylsulfone, 98.0%, 5g

(2E)-3-(2-hydroxyphenyl)acrylic acid, 98.0%, 5g

(R)-TERT-BUTYL 2-(2-(METHYLAMINO)THIAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 90.0%, 500mg

N-(3-(1H-INDOL-5-YL)-1H-INDAZOL-5-YL)-2,6-DICHLOROBENZAMIDE, 95%, 50mg

(2-(4-Methylpiperazin-1-yl)phenyl)methanamine, 95.0%, 1g

1,1-Dimethylethyl 2,3-dihydro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 100mg